688 related articles for article (PubMed ID: 24630619)
1. Clinical factors associated with absolute and relative measures of glycemic variability determined by continuous glucose monitoring: an analysis of 480 subjects.
Jin SM; Kim TH; Bae JC; Hur KY; Lee MS; Lee MK; Kim JH
Diabetes Res Clin Pract; 2014 May; 104(2):266-72. PubMed ID: 24630619
[TBL] [Abstract][Full Text] [Related]
2. Beyond HbA1c.
Bloomgarden Z
J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
[TBL] [Abstract][Full Text] [Related]
3. Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report.
Matsutani D; Sakamoto M; Iuchi H; Minato S; Suzuki H; Kayama Y; Takeda N; Horiuchi R; Utsunomiya K
Cardiovasc Diabetol; 2018 Mar; 17(1):36. PubMed ID: 29514695
[TBL] [Abstract][Full Text] [Related]
4. Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND Trial.
Ruedy KJ; Parkin CG; Riddlesworth TD; Graham C;
J Diabetes Sci Technol; 2017 Nov; 11(6):1138-1146. PubMed ID: 28449590
[TBL] [Abstract][Full Text] [Related]
5. Long-term glycemic control and glucose variability assessed with continuous glucose monitoring in a pediatric population with type 1 diabetes: Determination of optimal sampling duration.
Piona C; Marigliano M; Mozzillo E; Franzese A; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Delvecchio M; Maffeis C
Pediatr Diabetes; 2020 Dec; 21(8):1485-1492. PubMed ID: 32935887
[TBL] [Abstract][Full Text] [Related]
6. Defining the target value of the coefficient of variation by continuous glucose monitoring in Chinese people with diabetes.
Mo Y; Ma X; Lu J; Shen Y; Wang Y; Zhang L; Lu W; Zhu W; Bao Y; Zhou J
J Diabetes Investig; 2021 Jun; 12(6):1025-1034. PubMed ID: 33119969
[TBL] [Abstract][Full Text] [Related]
7. Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabetes.
Karter AJ; Parker MM; Moffet HH; Gilliam LK; Dlott R
JAMA; 2021 Jun; 325(22):2273-2284. PubMed ID: 34077502
[TBL] [Abstract][Full Text] [Related]
8. Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels.
Rama Chandran S; A Vigersky R; Thomas A; Lim LL; Ratnasingam J; Tan A; S L Gardner D
Diabetes Technol Ther; 2020 Feb; 22(2):103-111. PubMed ID: 31502876
[No Abstract] [Full Text] [Related]
9. Fasting and postprandial plasma glucose contributions to hemoglobin A1c and time in range in people with diabetes on multiple daily injection insulin therapy: Results from the PRONTO-T1D and PRONTO-T2D clinical trials.
Piras de Oliveira C; Dellva MA; Bue-Valleskey J; Chang AM; Liao B
J Diabetes Complications; 2024 Jan; 38(1):108648. PubMed ID: 38035641
[TBL] [Abstract][Full Text] [Related]
10. Glycaemia in low-premixed insulin analogue type 2 diabetes patients in a real-world setting: are the CGM targets met?
Krajnc M; Kravos Tramšek NA
Eur J Med Res; 2023 Mar; 28(1):111. PubMed ID: 36882852
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with glycemic variability in children with type 1 diabetes mellitus based on flash glucose monitoring system.
Zhang L; Guo K; Xu Y; Bai J; Ma Y; Fu L; Liu J; Hu K; Li X; Jiang H; Yang L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 47(4):462-468. PubMed ID: 35545341
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Reduced Self-Monitored Blood Glucose Testing After Adoption of Continuous Glucose Monitoring on Hemoglobin A1c and Time in Range.
Puhr S; Calhoun P; Welsh JB; Walker TC
Diabetes Technol Ther; 2018 Aug; 20(8):557-560. PubMed ID: 30036082
[TBL] [Abstract][Full Text] [Related]
13. The importance of HbA1c and glucose variability in patients with type 1 and type 2 diabetes: outcome of continuous glucose monitoring (CGM).
Sartore G; Chilelli NC; Burlina S; Di Stefano P; Piarulli F; Fedele D; Mosca A; Lapolla A
Acta Diabetol; 2012 Dec; 49 Suppl 1():S153-60. PubMed ID: 22466072
[TBL] [Abstract][Full Text] [Related]
14. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
Chan CL; Pyle L; Kelsey MM; Newnes L; Baumgartner A; Zeitler PS; Nadeau KJ
Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
[TBL] [Abstract][Full Text] [Related]
15. Visit-to-visit HbA1c variability is inversely related to baroreflex sensitivity independently of HbA1c value in type 2 diabetes.
Matsutani D; Sakamoto M; Minato S; Kayama Y; Takeda N; Horiuchi R; Utsunomiya K
Cardiovasc Diabetol; 2018 Jul; 17(1):100. PubMed ID: 29991356
[TBL] [Abstract][Full Text] [Related]
16. Relationship of continuous glucose monitoring-related metrics with HbA1c and residual β-cell function in Japanese patients with type 1 diabetes.
Babaya N; Noso S; Hiromine Y; Taketomo Y; Niwano F; Yoshida S; Yasutake S; Kawabata Y; Ikegami H
Sci Rep; 2021 Feb; 11(1):4006. PubMed ID: 33597626
[TBL] [Abstract][Full Text] [Related]
17. Distinct Patterns of Daily Glucose Variability by Pubertal Status in Youth With Type 1 Diabetes.
Zhu J; Volkening LK; Laffel LM
Diabetes Care; 2020 Jan; 43(1):22-28. PubMed ID: 31308020
[TBL] [Abstract][Full Text] [Related]
18. Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM).
Pettus J; Edelman SV
J Diabetes Sci Technol; 2016 Sep; 10(5):1087-93. PubMed ID: 27044518
[TBL] [Abstract][Full Text] [Related]
19. THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL.
Helleputte S; De Backer T; Calders P; Pauwels B; Shadid S; Lapauw B
Endocr Pract; 2021 Jan; 27(1):44-50. PubMed ID: 33475500
[TBL] [Abstract][Full Text] [Related]
20. Continuous glucose monitoring for glycaemic control and cardiovascular risk reduction in patients with type 2 diabetes not on insulin therapy: A clinical trial.
Reed J; Dong T; Eaton E; Friswold J; Porges J; Al-Kindi SG; Rajagopalan S; Neeland IJ
Diabetes Obes Metab; 2024 Jul; 26(7):2881-2889. PubMed ID: 38680050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
